Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 7 M8 M9 M11 M8 M8 M 36 M Research & development —————— — Operating income 253 M289 M211 M238 M252 M202 M 903 M Non-Operating Income, Total -330 M-373 M-444 M-416 M-408 M-337 M -1.6 B Interest expense, net of interest capitalized 187 M186 M188 M209 M210 M213 M 820 M Non-Operating Income, excl. Interest Expenses -517 M-559 M-632 M-625 M-618 M-550 M -2.42 B Unusual income/expense —————— — Pretax income -84 M-92 M-241 M-187 M-165 M401 M -192 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 357 M241 M361 M404 M293 M92 M 1.15 B Discontinued operations —————— — Net income 357 M241 M361 M404 M293 M92 M 1.15 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 357 M241 M361 M404 M293 M92 M 1.15 B Basic earnings per share (Basic EPS) 0.540.360.520.570.410.13 1.63 Diluted earnings per share (Diluted EPS) 0.540.360.520.570.410.13 1.63 Average basic shares outstanding 624 M676 M695 M709 M699 M718 M — Diluted shares outstanding 624 M676 M695 M709 M699 M718 M — EBITDA 257 M293 M215 M243 M256 M208 M 922 M EBIT 253 M289 M211 M238 M252 M202 M 903 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 4 M4 M4 M5 M4 M6 M 19 M